Gland Pharma Ltd

GLAND

Company Profile

  • Business description

    Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. The group is also involved in vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more - to Hormones and related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA.

  • Contact

    Plot No. 11 and 84, TSIIC Phase: IV
    Pashamylaram (V), Patancheru (M)
    Sangareddy District
    HyderabadTG502307
    IND

    T: +91 8455699999

    https://www.glandpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2025

    Employees

    4,217

Stocks News & Analysis

video

Do you qualify as 'rich'?

Morningstar's Sim Mody speaks with Mark LaMonica about the varying definitions of rich. 
stocks

Solid sales from ASX healthcare leader

Solid device sales with shares moderately undervalued.
stocks

Megatrend Investing: ASX players to capitalise on the clean energy transition

Find out how you can benefit from global megatrends.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,683.4050.000.58%
CAC 407,891.6814.72-0.19%
DAX 4021,585.9380.230.37%
Dow JONES (US)44,873.28317.240.71%
FTSE 1008,623.2952.520.61%
HKSE20,597.09192.87-0.93%
NASDAQ19,692.3338.310.19%
Nikkei 22538,831.4833.110.09%
NZX 50 Index12,844.5960.45-0.47%
S&P 5006,061.4823.600.39%
S&P/ASX 2008,416.9042.900.51%
SSE Composite Index3,229.4921.11-0.65%

Market Movers